Pharmaceuticals

Global Antibody Drug Conjugates Market Size, Forecasts, And Opportunities

December 2, 2021 by The Business Research Company

Learn about the global antibody drug conjugates market through The Business Research Company, which provides information on antibody drug conjugates market size, antibody drug conjugates market drivers and restraints, antibody drug conjugates market players, the COVID-19 impact on the antibody drug conjugates market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global antivirus software market is expected to grow from $2.34 billion in 2020 to $2.6 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antibody-drug conjugates (ADCs) market is expected to reach $6.12 billion in 2025 at a CAGR of 23.9%.

The rising incidences of cancer are expected to increase the demand for antibody drug conjugates driving market growth.

Request A Sample For The Global Antibody Drug Conjugates Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. ADCs are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumour-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

Global antibody drug conjugates market segments include:

By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Others

By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumour, Others

By Product: Adcetris, Kadcyla, Others

By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others

By End User: Hospital, Clinics, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business. For instance, in March 2019, AstraZeneca entered into a global development and commercialization collaboration agreement with Daiichi Sankyo Company for the proprietary antibody drug conjugate trastuzumab deruxtecan (DS-8201).

TBRC’s antibody drug conjugates market report covers:

Major Market Players: Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., and Oxford BioTherapeutics.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides antibody drug conjugates market overviews, analyzes and forecasts market size, share, antibody drug conjugates market players, antibody drug conjugates market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s antibody drug conjugates market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Conjugated Monoclonal Antibodies Global Market Report 2021

Brain Tumor Drugs Global Market Report 2021

Monoclonal Antibodies (MAbS) Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model